| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |